Waste
We are committed to reducing our operational waste, as well as reducing the environmental impact of our products and packaging.
| Biopharma | Consumer Healthcare | |
|---|---|---|
| Operational Waste | Zero operational waste, including eliminating single use plastics[1], by 2030 | All manufacturing sites to achieve TRUE Certification by 2030 |
| Products and Packaging | 25% environmental impact reduction for our products and packaging by 2030 |
|
| Supply Chain | 10% waste reduction from supply chain by 2030 |
|
Operational waste and single-use plastics
We will achieve zero operational waste through minimising the amount of waste we generate - both hazardous and non-hazardous - and diverting the material we do generate into circular cycles, for example reuse, recycling and composting.
Our commitment to operational waste includes eliminating single use plastics in our operations by 2030 (excluding those plastics which are critical to product discovery and development, health and safety, and meeting regulatory obligations).
Products and product packaging
The Biopharma business has committed to a 25% environmental impact reduction for product and packaging by 2030. We will achieve this through integrating environmental aspects into the product design process for all new products and selected established products, with the aim of improving the environmental performance of the product throughout its whole life cycle, for example by using recycled card in packaging, using e-leaflets for vaccines and using more efficient manufacturing methods.
The Biopharma business is working with suppliers to understand and map our waste in the supply chain. We can then baseline our supply chain waste impact and work with suppliers to develop action plans to achieve our target.
The Consumer Healthcare Business has committed to developing solutions for all product packaging to be recycle-ready by 2025, a key milestone towards making all our packaging recyclable or reusable by 2030. We are delivering flagship projects to reduce our plastic packaging footprint, including moving to recycle-ready toothpaste tubes. We manufactured over 40 million recycle-ready tubes for over 20 markets in 2021.
GSK is a member of the Ellen McArthur Foundation to help develop our approach to circularity and to work with other members on collaborative projects for mutual benefit.
Protecting and restoring the planet’s health to protect and improve people’s health
In November 2020, we announced ambitious environmental sustainability goals in both climate and nature.
Read more about our goals.
Find out more
-
Carbon
We are working to reduce emissions from our entire value chain while extending access to our products for the people who need them.
-
Water
By better understanding our water use across the value chain, we can focus our efforts where we can make the biggest difference
-
Environmental stewardship
We are taking steps to ensure that raw materials, such as wood-based packaging materials and palm oil are sourced responsibly.
-
Responsibility reports & data
Find out about our responsible business performance in our Responsible Business Supplement and other historical resources
